Fundraising Fox

Jacques Theurillat

Investor

Partner at Sofinnova Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Jacques joined Sofinnova Partners in 2017 as a Partner in the Crossover Strategy, bringing extensive experience in biopharmaceutical operations and both private and public investing. He co-founded and managed Ares Life Sciences in 2008, deploying €1.25 billion across six life sciences companies, and previously spent nearly 20 years at the Serono pharmaceutical group in senior roles including deputy CEO, CFO, and head of strategic corporate development.

Invests in

Biotech

Investments

Investor

Bronchus Technologies IncEsaote SpaEuromedic International BVGreer IncSanthera PharmaceuticalsStallergenes SA

Per the firm's website.

Colleagues at Sofinnova Partners

Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners

Network3

Anne Osdoit
Partner, MD Start Strategy at Sofinnova Partners
Anta Gkelou
Partner, Capital Strategy at Sofinnova Partners
Gonzague Issenmann
Investor at Sofinnova Partners

Investors connected to Jacques in public investor directories — a warm-intro map.